Meeting Banner
Abstract #1847

Magnetic Resonance Imaging (MRI) Assessment of Dimethyl Fumarate in Protecting Myelin in a Cuprizone Mouse Model

Peter Cheng-te Chou1, Benxiu Ji2, Jon Archbold1, Ankur Thomas2, Davide Gianni2, Daniel Bradley1, Haiying Liu1, and Brian Wipke2

1Research and Early Development Biomarker, Biogen, Cambridge, MA, United States, 2Neuroimmunology and Acute Neurology Research Unit, Biogen, Cambridge, MA, United States

Multiple sclerosis (MS) is a debilitating disease that affects the central nervous system. Immune system destroys the myelin that protects the axon which leads to physical, neurocognitive, and psychiatric disorders. Symptoms may improve, but permanent neurological problems often remain. There is no known cure for MS but current treatments can improve symptoms and prevent relapse. MRI has a role in MS diagnosis and management. We demonstrated that advances in MRI techniques such as Magnetization Transfer Ratio Imaging and Diffusion Tensor Imaging can detect the protective effects of dimethyl fumarate, clinically approved MS treatment, in the corpus callosum of mice.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords